There were 654 confirmed and 30 probable cases at the end of April. The number of confirmed cases has jumped to 725, while there are still 30 probable cases in the country.
Cases of the deadly emerging fungus have been reported in 12 states. New York, Illinois and New Jersey have experienced the highest number of cases, with each state reporting more than 100. New York has reported 355 confirmed cases.
Additionally, 1,474 patients have been found to be colonized with C. auris.
C. auris cases have also been reported in several countries around the world.
C. auris, a type of yeast, is often multidrug-resistant and causes bloodstream infections, wound infections and ear infections. A recent study shows that patients heavily colonized with C. auris can contaminate their surroundings by shedding the fungus from their skin.
More articles on healthcare quality:
Jewish Hospital cancels suspension of Louisville heart transplant program
1st death reported amid uptick in vaping-related illnesses
Why vaccine stock photos are getting a makeover
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
